Dyslipidaemia in Type 1 Diabetes: Molecular Mechanisms and Therapeutic Opportunities

Cardiovascular disease (CVD) is the leading cause of death in Type 1 Diabetes (T1D). The molecular basis for atherosclerosis in T1D is heavily influenced by hyperglycaemia and its atherogenic effects on LDL. Ongoing research into the distinct pathophysiology of atherosclerosis in T1D offers exciting...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Brien, Stephen T., Neylon, Orla M., O’Brien, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301346/
https://www.ncbi.nlm.nih.gov/pubmed/34356890
http://dx.doi.org/10.3390/biomedicines9070826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301346/
https://www.ncbi.nlm.nih.gov/pubmed/34356890
http://dx.doi.org/10.3390/biomedicines9070826

Ejemplares similares